Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Latest reported DNTH revenue for 2026-06-30 was $17.8M. Net income was -$91.0M. DNTH currently screens at market cap $4.40B.
Use this DNTH page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the DNTH quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the DNTH SEC filings page. Lician reads the product cache first so this HTML stays unique to Dianthus Therapeutics Inc. even when a live quote feed is slow.
Latest cached year on this hub. Full DNTH income, balance, and cash tables.